Aoxin‌ Q&M Dental CEO Resigns Amidst Whistleblower Report and financial Dispute

Singapore companies, ⁤Healthcare, ‍CEO, Whistleblowers, The Business Times

Aoxin Q&M Dental, a ⁣prominent operator of dental hospitals and polyclinics across four cities in china’s Liaoning province, has seen ⁢its Chief executive Officer, Dr. Shao, resign. This progress follows a significant financial dispute and a whistleblower report ⁢lodged‌ against him.The company, which also engages in the distribution of dental equipment and ⁤supplies, has been embroiled in a legal and financial entanglement with its parent company, Q&M Dental.

Financial Dispute and Profit Guarantees

The core of the dispute appears to stem from an acquisition ‌made by Q&M Dental’s subsidiary, Shanghai Q&M Investment Management‍ & Consulting, which ‌acquired Shenyang Xinao Hospital Management from Dr.Shao. In October 2016, Q&M Dental claims that Dr. Shao provided certain ‌profit⁤ guarantees in relation to⁣ this acquisition.

This led Q&M dental to issue a letter of demand to Dr. Shao in April,seeking approximately 72.3 million yuan​ (S$12.9 million). ⁢The​ demand highlights a significant financial obligation that Q&M Dental believes Dr. shao owes⁣ the ‍company.

Mandatory Offer‌ and ⁤Trading Halt

Adding‌ to the complexity, Q&M⁤ Dental made a mandatory unconditional cash ⁤offer in‍ May for all the shares in Aoxin Q&M that ⁤it did ‌not already own. This move ⁤suggests a potential ​consolidation or a move to gain full control of the‌ subsidiary.

The market ⁣reacted to⁤ the unfolding situation. ‌Shares ⁤of Aoxin Q&M Dental⁤ closed 8 per cent, or 0.4 cents lower, at​ 4.6 cents on July 21. The company subsequently⁤ called for a trading halt before the⁤ market opened on July 22. The trading halt was requested to be lifted later in the session, coinciding with the declaration of Dr. Shao’s resignation. This ‍sequence of events underscores the sensitive nature of the⁣ information being ‌disclosed and its immediate impact on the‌ company’s‌ stock performance.

The resignation ​of Dr. Shao, coupled with the ongoing financial dispute and the whistleblower report, marks a critical juncture ⁣for Aoxin Q&M Dental. The ‍company’s​ future operations and its relationship with ⁤Q&M Dental will likely⁣ be⁣ closely watched by investors​ and industry observers alike.